2018
DOI: 10.5935/2238-3182.20180069
|View full text |Cite
|
Sign up to set email alerts
|

Drugs with activity on the cytochrome P450 used by elderly at home

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
2
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 14 publications
0
2
0
1
Order By: Relevance
“…Drugs that act on the same subfamily of CYP450 enzymes, when administered concomitantly, can interact with each other, and affect the systemic clearance of one of them and result in reduced effectiveness, synergism or toxicity (Braz, Figueiredo, Barroso & Reis, 2018). The nature, extent and clinical relevance of these drug interactions depend on whether the drug exerts substrate activity, where the structure competes for metabolization in the same CYP, which can cause an inductive effect and an increase in the enzymatic process speed, resulting in a accelerated metabolism of the xenobiotic and/or CYP450 enzyme inhibitor, where there is a reduction in metabolism rate with prolonged effects and toxicity (Hakkola et al, 2020).…”
Section: Cyp450 (Cytochrome P450mentioning
confidence: 99%
See 1 more Smart Citation
“…Drugs that act on the same subfamily of CYP450 enzymes, when administered concomitantly, can interact with each other, and affect the systemic clearance of one of them and result in reduced effectiveness, synergism or toxicity (Braz, Figueiredo, Barroso & Reis, 2018). The nature, extent and clinical relevance of these drug interactions depend on whether the drug exerts substrate activity, where the structure competes for metabolization in the same CYP, which can cause an inductive effect and an increase in the enzymatic process speed, resulting in a accelerated metabolism of the xenobiotic and/or CYP450 enzyme inhibitor, where there is a reduction in metabolism rate with prolonged effects and toxicity (Hakkola et al, 2020).…”
Section: Cyp450 (Cytochrome P450mentioning
confidence: 99%
“…Drug interactions resulting from the inhibition of CYP450 enzymes are more frequent than those caused by enzyme induction, and generally occur when the inhibitor is a substrate and compete directly for the enzyme's binding site (Braz et al, 2018).…”
Section: Cyp450 (Cytochrome P450mentioning
confidence: 99%
“…Entretanto, há drogas que afetam a expressão do gene relacionado a esta enzima e podem modular a ativação de D 3 . Inúmeros fármacos atuam como indutores e outros como inibidores da atividade da CYP3A4, podendo ocasionar possíveis interações medicamentosas e interferência na ativação de D 3 20 .…”
Section: Aspectos Fisiológicos Ambientais Nutricionais E Genéticosunclassified
“…Todas as moléculas podem inibir CYP (Tabela 5), quando administrados concomitantemente com fármacos metabolizados pela enzima, podem interagir entre si e afetar o clearance sistêmico. A extensão e relevância clínica desta interação depende se o fármaco exerce atividade de substrato, indutor e/ou inibidor de enzimas CYP450 (Cheng, Frishman & Aronow, 2009;Braz, et al, 2018).…”
Section: Antineoplásicaunclassified